Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"KPT-8602" - Google News
Get the latest updates from "KPT-8602" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress - marketscreener.com
about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and...
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress - GuruFocus.com
about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and...
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress - BioSpace
about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and...
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress - BioSpace
about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and...
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress - Stockhouse
about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and...
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress - Yahoo Finance
about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and...
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress - PRNewswire
about 2 years ago
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and...
FDA Grants Orphan Drug Designation to Eltanexor for Myelodysplastic Syndrome - Targeted Oncology
over 2 years ago
FDA Grants Orphan Drug Designation to Eltanexor for Myelodysplastic Syndrome Targeted Oncology
FDA Grants Orphan Drug Designation to Eltanexor for Myelodysplastic Syndromes - OncLive
over 2 years ago
FDA Grants Orphan Drug Designation to Eltanexor for Myelodysplastic Syndromes OncLive
Karyopharm Receives Orphan Drug Designation from FDA for Eltanexor for the Treatment of Myelodysplastic Syndromes - PRNewswire
over 2 years ago
Karyopharm Receives Orphan Drug Designation from FDA for Eltanexor for the Treatment...
Karyopharm Receives Orphan Drug Designation from FDA for Eltanexor for the Treatment of Myelodysplastic Syndromes - Yahoo Finance
over 2 years ago
Karyopharm Receives Orphan Drug Designation from FDA for Eltanexor for the Treatment...
ATG-016 for Solid Tumors Begins Dosing in Early Trial - Targeted Oncology
over 2 years ago
ATG-016 for Solid Tumors Begins Dosing in Early Trial Targeted Oncology